References: 1. Instructions for Patient Use. P/N 2610-00 Rev. B 06/2020.
The V-Go series of Wearable Insulin Delivery Devices are indicated for continuous subcutaneous infusion of either 20 Units of insulin (0.83 U/hr), 30 Units of insulin (1.25 U/hr) or 40 Units of insulin (1.67 U/hr) in one 24-hour time period and on-demand bolus dosing in 2-Unit increments (up to 36 Units per one 24-hour time period) in adults requiring insulin.
V-Go is magnetic resonance (MR) unsafe. Remove V-Go before X-ray, MRI or CT scan and replace it with a